Litigation Details for Galderma Laboratories LP v. Actavis Laboratories UT Inc (N.D. Tex. 2017)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2017-04-21
Court	District Court, N.D. Texas	Date Terminated	2017-12-11
Cause	35:271 Patent Infringement	Assigned To	Barbara M. Lynn
Jury Demand	Plaintiff	Referred To
Parties	GALDERMA LABORATORIES LP
Patents	8,815,816; 9,089,587; 9,233,117; 9,233,118; 9,782,425
Attorneys	Thomas F Fleming
Firms	Carter Scholer Arnett Mockler, Trammel Crow Center
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-04-21	1		US Patent No. 8,362,069, # 2 Exhibit(s) B - US Patent No. 8,815,816, # 3 Exhibit(s) C - US Patent No.…9,089,587, # 4 Exhibit(s) D - US Patent No. 9,233,117, # 5 Exhibit(s) E - US Patent No. 9,233,118, # 6 Cover …2017 3:17-cv-01076 830 Property Rights: Patent Plaintiff District Court, N.D. Texas	External link to document
2017-11-16	60		infringement of U.S. Patent Nos. 8,815,816 (the “‘816 Patent”); 9,089,587 (the “‘587 Patent”); 9,233,117 (“…“‘117 Patent”); 9,233,118 (the “‘118 Patent”); and U.S. Patent Nos. 8,362,069 (the “‘069 Patent”). The… claims of the ‘816 Patent, ‘587 Patent, ‘117 Patent, and ‘118 Patent are invalid…location of the patent holder is relevant to the patent venue analysis, and the patent venue statute does… seeks to add a related patent, U.S. Patent No. 9,782,425 (the “‘425 Patent”) that did not exist when	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document